Is the race to build human‑like machines running too fast for its own good? That’s a question now looming over China’s humanoid robotics sector, as the country’s top economic‑planning agency warns of an emerging bubble in one of the most hyped technology markets in the world.
The sector has grown at breakneck pace in China over the past year, with more than 150 companies building robots designed to mimic human form and motion. Massive state investment including a planned 1 trillion yuan fund for robotics and AI has driven the surge, alongside a string of viral demonstrations of robots dancing, kickboxing, and even running half-marathons. Citigroup said it expects “exponential” growth in production next year, driven largely by China, which it predicts will make up more than half the world’s total output of humanoid robots.
“Highly similar models” glut the market and risk crowding out genuine research and development, said Li Chao, a commission spokesman. That kind of congestion recalls earlier technology manias-from bike‑sharing to semiconductors-in which overinvestment led to rapid consolidation and the collapse of weaker players. In economic terms, such bubbles form when speculative capital inflates valuations far beyond the technological or commercial readiness of the industry underlying it, leaving it open to sharp corrections.
The engineering reality underlying humanoid robotics underlines the reason why that warning will matter: while publicly impressive, developers still grapple with unsolved challenges in everything from super‑dexterous hands to whole‑body control systems. Manipulation-that is, the ability to grasp, adjust, and interact with objects with the same fluidity as humans-remains a bottleneck. Most industrial robots use either parallel jaw grippers or suction cups, technologies that are robust but far less versatile than the human hand. So far, efforts to replicate human‑like dexterity with articulated fingers have failed to yield designs capable of withstanding industrial workloads or generalizing across diverse tasks. Without breakthroughs here, the promise of humanoids seamlessly replacing human labor in existing workflows remains technically constrained.
Competitive advantage for China lies in its manufacturing ecosystem. From planetary roller screws to six‑dimensional force sensors, the country controls as much as 90% of humanoid robot components and is able to deliver parts in hours. That supply chain dominance allows for aggressive cost‑cutting: Unitree’s G1 humanoid launched at $16,000, undercutting U.S. rivals such as Tesla’s Optimus Gen2, which analysts estimate could cost about $20,000 only if it scales with Chinese‑sourced components. Bain & Company projects that production costs may fall 60–70% over the coming decade, with bill‑of‑materials falling to $10,000–$20,000 by 2035. But such economies of scale can mask systemic risks. When too many firms chase the same designs and price points, margins shrink and R&D budgets suffer.
The Solactive China Humanoid Robotics Index which tracks the sector stocks leapt almost 60% earlier this year before pulling back by almost 20%, a volatility pattern familiar to investors who witnessed the AI stock boom. More than 70% of humanoid and service robot start-ups remain loss‑making despite headline‑grabbing prototypes. A bursting bubble would send shockwaves across the global robotics market. Costs are being driven down and rollout timelines accelerated by Chinese firms; meanwhile, a squeeze on funding could slow the arrival of affordable humanoids around the world. Consolidation would then likely ensue, with smaller companies absorbed or shuttered, which would temporarily decrease competition for U.S. players. American firms might benefit from cheaper Chinese components and talent during the shakeout; however, such benefits would be short-lived, with surviving Chinese giants likely to restructure and regain momentum.
The stakes exceed economics: Beijing views humanoid robots as a strategic tool in resolving looming labor shortages, especially in manufacturing and elderly care. Government procurement of humanoid robots leaped from 4.7 million yuan in 2023 to 214 million yuan in 2024, while policy guidelines demanded “production at scale” by 2025. If that bubble were to deflate early, these social and industrial goals might be delayed-forcing China to recalculate its strategy for automation. Li Chao’s warning helps point out that investors and industry watchers must remember how, even in frontier sectors, technological maturity ought to keep pace with market enthusiasm. The engineering hurdles in humanoid robotics, right from dexterous manipulation to reliable whole‑body control, are as real as the financial risks.
